Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pemafibrate for Treating NAFLD Complicated by Hypertriglyceridemia: A Multi-center, Open Study, Randomized Controlled Trial (PRESENT Study)

NCT06623539 is registered in ClinicalTrials.gov with Yokohama City University as lead sponsor.

NCT NCT06623539
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06623539 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pemafibrate for Treating NAFLD Complicated by Hypertriglyceridemia: A Multi-center, Open Study, Randomized Controlled Trial (PRESENT Study)
Lead sponsor
Yokohama City University
Phase
Phase 2
Overall status
Active, not recruiting
Start date
December 23, 2020
Completion date
March 31, 2026
Enrollment
360 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non alcoholic fatty liver disease